Imovax Polio 29 Unit

Imovax Polio is a vaccine designed to protect against poliovirus type 1. This inactivated solution is administered subcutaneously and is manufactured by Sanofi Pasteur Limited.

Imovax Polio is used to prevent polio, a viral infection that can cause paralysis. It is typically administered to individuals who are at risk of exposure to the poliovirus. The vaccine works by stimulating the body's immune system to produce antibodies against the virus, providing protection against future infections.

Common effects of Imovax Polio may include mild redness, swelling, or pain at the injection site. Some individuals may experience mild fever, headache, or fatigue. These effects are usually temporary and resolve on their own.

Imovax Polio should be stored as directed by the manufacturer to maintain its effectiveness. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Follow the advice of a healthcare professional regarding the administration and any potential side effects.

Imovax Polio may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Imovax Polio. Avoid alcohol or other substances that may affect the immune system.